These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7268235)

  • 1. [Plasma cell leukemia. Report of a patient with unusually good response to treatment (author's transl)].
    Gómez Almaguer D; Moscoso Zaldaño C; Labardini Méndez JR
    Rev Invest Clin; 1981; 33(1):71-3. PubMed ID: 7268235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma cell leukaemia. Haematological features and response to treatment (author's transl)].
    Fernández Rañada JM; Ribera C; López Pascual J; Salazar DG; Talero D; Montero J
    Sangre (Barc); 1975; 20(4):498-504. PubMed ID: 1216078
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
    Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
    Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgM multiple myeloma. Case report and review of the literature [].
    Marín-López A; Landero de Ruiz N; Armenta Olvera T; Ruiz-Argüelles GJ
    Rev Invest Clin; 1982; 34(2):175-8. PubMed ID: 7123028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case of plasmacytic leukemia with complete remission and 1-year survival after a combined 5-drug sequence therapy].
    Anisimowicz J; Mizan K
    Pol Tyg Lek; 1984 Sep; 39(36):1209-10. PubMed ID: 6504747
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmacytic leukemia. Apropos of a case with prolonged survival after polychemotherapy].
    Fuzibet JG; Gratecos N; Cassuto JP; Dujardin P
    Nouv Presse Med; 1981 Jul 11-25; 10(30):2519. PubMed ID: 7267359
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
    Katodritou E; Verrou E; Gastari V; Hadjiaggelidou C; Terpos E; Zervas K
    Leuk Res; 2008 Jul; 32(7):1153-6. PubMed ID: 18083228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell leukemia--report on two cases.
    Singh VP; Sundar S; Kumar K; Shukla J; Dube B
    J Assoc Physicians India; 1994 Oct; 42(10):824-5. PubMed ID: 7876056
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
    Shindo T; Yumoto Y; Yoshida M; Okuda T
    Rinsho Ketsueki; 2002 Feb; 43(2):107-11. PubMed ID: 11925872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective cytotoxic treatment of primary plasma cell leukaemia--a report of 3 cases.
    Gangadharan VP; Satishkumar K; Pillai R; Cherian V
    Acta Oncol; 1994; 33(6):714-5. PubMed ID: 7946458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma cell leukemia: a case with sustained complete remission (author's transl)].
    Bourdesoule D; Marty M; Brouet JC; Unger P; Boiron M
    Nouv Presse Med; 1981 Feb; 10(9):709. PubMed ID: 7208312
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of the successful treatment of acute plasmablastic leukemia].
    Rekhtina IG; Shchekochikhin SM
    Ter Arkh; 1997; 69(11):70-1. PubMed ID: 9483754
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of prophylactic treatment of central nervous system leukemia in children (author's transl)].
    Yokoyama T; Kuriya N; Hiyoshi Y; Hasegawa K; Ito M; Kim PY; Fujimoto T
    Rinsho Ketsueki; 1980 Nov; 21(11):1720-8. PubMed ID: 6894173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Three cases of plasma cell leukemia--therapeutic effect and cytologic study (author's transl)].
    Ota H; Ikeda Y; Kakizawa H
    Rinsho Ketsueki; 1974 Feb; 15(2):201-9. PubMed ID: 4858698
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
    Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
    Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of plasma cell leukemia].
    Fülle HH; Pribilla W
    Dtsch Med Wochenschr; 1973 Apr; 98(17):874-81. PubMed ID: 4571885
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.
    Sajeva MR; Greco MM; Cascavilla N; D'Arena G; Scalzulli P; Melillo L; Minervini MM; Bonini A; Di Mauro L; Carotenuto M; Musto P
    Bone Marrow Transplant; 1996 Jul; 18(1):225-7. PubMed ID: 8832022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of plasma cell leukemia (author's transl)].
    Ishige K; Takagi T; Oguro M; Majima H
    Rinsho Ketsueki; 1978 Mar; 19(3):272-9. PubMed ID: 702813
    [No Abstract]   [Full Text] [Related]  

  • 19. Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy.
    Pretz J; Medeiros BC
    Am J Hematol; 2009 Oct; 84(10):698-9. PubMed ID: 19691102
    [No Abstract]   [Full Text] [Related]  

  • 20. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.